| Cisplatin-stitched polysaccharide vesicles for synergistic cancer therapy of triple antagonistic drugs NU Deshpande, M Jayakannan Biomacromolecules 18 (1), 113-126, 2017 | 51 | 2017 |
| Targeting PI3K pathway in pancreatic ductal adenocarcinoma: rationale and progress S Mehra, N Deshpande, N Nagathihalli Cancers 13 (17), 4434, 2021 | 49 | 2021 |
| Biotin-tagged polysaccharide vesicular nanocarriers for receptor-mediated anticancer drug delivery in cancer cells NU Deshpande, M Jayakannan Biomacromolecules 19 (8), 3572-3585, 2018 | 49 | 2018 |
| Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer A Bianchi, I De Castro Silva, NU Deshpande, S Singh, S Mehra, ... Cancer discovery 13 (6), 1428-1453, 2023 | 32 | 2023 |
| Real-time drug release analysis of enzyme and pH responsive polysaccharide nanovesicles PS Pramod, NU Deshpande, M Jayakannan The Journal of Physical Chemistry B 119 (33), 10511-10523, 2015 | 27 | 2015 |
| An AIE-driven fluorescent polysaccharide polymersome as an enzyme-responsive FRET nanoprobe to study the real-time delivery aspects in live cells NU Deshpande, M Virmani, M Jayakannan Polymer Chemistry 12 (10), 1549-1561, 2021 | 24 | 2021 |
| Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer J Datta, A Bianchi, I De Castro Silva, NU Deshpande, LL Cao, S Mehra, ... Oncogene 41 (28), 3640-3654, 2022 | 20 | 2022 |
| Engineered multifunctional nano‐and biological materials for cancer immunotherapy A Brouillard, N Deshpande, AA Kulkarni Advanced Healthcare Materials 10 (6), 2001680, 2021 | 18 | 2021 |
| Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized … I de Castro Silva, A Bianchi, NU Deshpande, P Sharma, S Mehra, ... Elife 11, e78921, 2022 | 17 | 2022 |
| Polymer nanovesicle-mediated delivery of MLN8237 preferentially inhibits Aurora kinase a to target RalA and anchorage-independent growth in breast cancer cells S Inchanalkar, NU Deshpande, V Kasherwal, M Jayakannan, ... Molecular Pharmaceutics 15 (8), 3046-3059, 2018 | 11 | 2018 |
| Supramolecular polysaccharide nanotheranostics that inhibit cancer cells growth and monitor targeted therapy response N Deshpande, A Ramesh, D Nandi, A Nguyen, A Brouillard, A Kulkarni Nanotheranostics 4 (3), 156, 2020 | 8 | 2020 |
| Self-reporting polysaccharide polymersome for doxorubicin and cisplatin delivery to live cancer cells M Virmani, NU Deshpande, S Pathan, M Jayakannan ACS Polymers Au 2 (3), 181-193, 2021 | 6 | 2021 |
| Ras-p53 genomic cooperativity as a model to investigate mechanisms of innate immune regulation in gastrointestinal cancers AR Dosch, WK Chatila, Y Ban, A Bianchi, NU Deshpande, IDC Silva, ... Oncotarget 12 (20), 2104, 2021 | 5 | 2021 |
| Activatable Nanoreporters for Real‐Time Tracking of Macrophage Phenotypic States Associated with Disease Progression A Ramesh, N Deshpande, V Malik, A Nguyen, M Malhotra, M Debnath, ... Small 19 (41), 2300978, 2023 | 1 | 2023 |
| Abstract C021: Granulocytic MDSC-derived NLRP3 inflammasome activation is a novel regulator of inflammatory CAF skewness in pancreatic cancer K Rajkumar, NU Deshpande, I de Castro Silva, A Bianchi, I Ogobuiro, ... Cancer Research 84 (2_Supplement), C021-C021, 2024 | | 2024 |
| Granulocytic MDSC-derived NLRP3 inflammasome activation is a novel regulator of inflammatory CAF skewness in pancreatic cancer K Rajkumar, NU Deshpande, IC Silva, A Bianchi, I Ogobuiro, H Amirian, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
| Cell-specific nanoengineering strategy disrupts tolerogenic signaling from myeloid-derived suppressor cells to invigorate antitumor immunity in pancreatic cancer NU Deshpande, A Bianchi, H Amirian, I De Castro Silva, CI Rafie, ... bioRxiv, 2024.05. 25.594901, 2024 | | 2024 |
| KRAS-TP53 cooperativity regulates Cxcl1 to sustain tumor-permissive circuitry via granulocyte-derived CXCR2-TNF signaling in pancreatic cancer. A Bianchi, IDC Silva, NU Deshpande, S Mehra, VT Garrido, S Singh, ... CANCER RESEARCH 82 (22), 132-133, 2022 | | 2022 |
| Targeting granulocytic MDSC-derived inflammasome activation to overcome stromal inflammation in pancreatic cancer. N Deshpande, A Bianchi, IDC Silva, V Garrido, S Mehra, S Singh, ... CANCER RESEARCH 82 (22), 130-131, 2022 | | 2022 |
| Targeting tumor intrinsic p38 MAPK signaling to block IL-1a-mediated inflammatory tumor-stromal crosstalk in pancreatic cancer. SP Singh, AR Dosch, S Mehra, IC Silva, A Bianchi, V Tonin-Garrido, ... CANCER RESEARCH 82 (22), 151-152, 2022 | | 2022 |
